Innovative Eyewear (LUCY) Cash from Financing Activities (2021 - 2025)
Innovative Eyewear (LUCY) reported Cash from Financing Activities of $336965.0 for Q4 2025, up 275.03% on a YoY basis from $89851.0 in Q4 2024, and down 42.34% sequentially from $584402.0 in Q3 2025.
Innovative Eyewear (LUCY) Cash from Financing Activities (2021 - 2025) Analysis & Trends
Innovative Eyewear (LUCY) has 5 years of Cash from Financing Activities data on file, last reported at $336965.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities rose 275.03% year-over-year to $336965.0; the trailing twelve-month figure through Dec 2025 stood at $6.0 million (down 40.99% YoY), and the FY2025 full-year result was $6.7 million, down 34.77% from the prior year.
- Cash from Financing Activities fell to $336965.0 in Q4 2025, from $584402.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $6.0 million in Q3 2022 to a low of -$285137.0 in Q4 2023.
- A 5-year average of $1.6 million and a median of $481528.0 in 2021 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities slumped 145.15% in 2022 and soared 24865.23% in 2024, its largest moves.
- Tracing LUCY's Cash from Financing Activities over 5 years: stood at $449593.0 in 2021, then tumbled by 145.15% to -$203000.0 in 2022, then plunged by 40.46% to -$285137.0 in 2023, then soared by 131.51% to $89851.0 in 2024, then soared by 275.03% to $336965.0 in 2025.
- Business Quant data shows LUCY's Cash from Financing Activities at $336965.0 in Q4 2025, $584402.0 in Q3 2025, and $89851.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Innovative Eyewear | 2.79 Mn | -4.99 Mn | 114,746.00 | 336,965.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336,965.00 |
| Dec 31, 2025 | 336,965.00 |
| Sep 30, 2025 | 584,402.00 |
| Sep 30, 2025 | 584,402.00 |
| Dec 31, 2024 | 89,851.00 |
| Dec 31, 2024 | 89,851.00 |
| Sep 30, 2024 | 5.03 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Mar 31, 2024 | -75,988.00 |
| Mar 31, 2024 | -75,988.00 |
| Dec 31, 2023 | -285,137.00 |
| Dec 31, 2023 | -285,137.00 |
| Sep 30, 2023 | -20,325.00 |
| Sep 30, 2023 | -20,325.00 |
| Jun 30, 2023 | 5.61 Mn |
| Jun 30, 2023 | 5.61 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.36 Mn |